Syros Pharmaceuticals Future Growth

How is Syros Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

40.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:SYRS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	56	-109	N/A	N/A	4
12/31/2024	14	-142	N/A	N/A	4
12/31/2023	17	-129	N/A	N/A	6
9/30/2022	23	-114	-116	-115	N/A
6/30/2022	25	-109	-108	-107	N/A
3/31/2022	24	-97	-109	-108	N/A
12/31/2021	23	-87	-101	-100	N/A
9/30/2021	21	-93	-108	-106	N/A
6/30/2021	20	-86	-95	-94	N/A
3/31/2021	18	-81	-81	-80	N/A
12/31/2020	15	-84	-61	-57	N/A
9/30/2020	10	-74	-50	-38	N/A
6/30/2020	7	-74	-48	-34	N/A
3/31/2020	4	-76	-54	-40	N/A
12/31/2019	2	-75	-73	-60	N/A
9/30/2019	2	-74	-68	-63	N/A
6/30/2019	2	-70	-65	-62	N/A
3/31/2019	2	-64	-60	-58	N/A
12/31/2018	2	-62	-42	-40	N/A
9/30/2018	1	-60	-38	-37	N/A
6/30/2018	1	-58	-37	-37	N/A
3/31/2018	0	-57	-35	-34	N/A
12/31/2017	1	-54	-46	-45	N/A
9/30/2017	1	-50	-45	-44	N/A
6/30/2017	1	-50	-45	-43	N/A
3/31/2017	1	-51	-44	-43	N/A
12/31/2016	0	-51	-43	-41	N/A
9/30/2016	N/A	-52	-41	-39	N/A
6/30/2016	N/A	-48	N/A	-35	N/A
3/31/2016	0	-41	N/A	-30	N/A

Earnings vs Savings Rate: SYRS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SYRS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SYRS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SYRS's revenue (63.2% per year) is forecast to grow faster than the US market (7.1% per year).

High Growth Revenue: SYRS's revenue (63.2% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if SYRS's Return on Equity is forecast to be high in 3 years time